Fusion Antibodies plc (AIM:FAB)
London · Delayed Price · Currency is GBP · Price in GBX 10.22
-0.53 (-4.92%)
Jul 24, 2026, 4:09 PM GMT
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 13.44 million as of July 24, 2026. Its market cap has increased by 31.39% in one year.
Market Cap
13.44M
Enterprise Value
13.58M
Revenue
1.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.22
ChartMarket Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 13.44M, a decrease of -50.74%. That is a compound annual growth rate of -7.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 13.44M | -15.54% |
| Dec 31, 2025 | 15.91M | 135.22% |
| Dec 31, 2024 | 6.76M | 167.72% |
| Dec 29, 2023 | 2.53M | -78.42% |
| Dec 30, 2022 | 11.71M | -59.09% |
| Dec 31, 2021 | 28.62M | -9.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sareum Holdings | 32.56M |
| SkinBioTherapeutics | 30.45M |
| ImmuPharma | 24.96M |
| Arecor Therapeutics | 23.98M |
| IXICO | 18.53M |
| Aptamer Group | 16.41M |
| Palatin Technologies | 12.78M |
| Genflow Biosciences | 10.76M |